Belçika - İngilizce - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - disodium pamidronate 3 mg/ml - eq. pamidronic acid 2,527 mg/ml - concentrate for solution for infusion - 3 mg/ml - pamidronate disodium 3 mg/ml - pamidronic acid

Belçika - İngilizce - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - disodium pamidronate 3 mg/ml - eq. pamidronic acid 2,527 mg/ml - concentrate for solution for infusion - 3 mg/ml - pamidronate disodium 3 mg/ml - pamidronic acid

Belçika - İngilizce - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - disodium pamidronate 3 mg/ml - eq. pamidronic acid 2,527 mg/ml - concentrate for solution for infusion - 3 mg/ml - pamidronate disodium 3 mg/ml - pamidronic acid

Kanada - İngilizce - Health Canada

pharmascience inc - pamidronate disodium - powder for solution - 30mg - pamidronate disodium 30mg - bone resorption inhibitors

Kanada - İngilizce - Health Canada

pharmascience inc - pamidronate disodium - powder for solution - 90mg - pamidronate disodium 90mg - bone resorption inhibitors

Kanada - İngilizce - Health Canada

pharmascience inc - pamidronate disodium - powder for solution - 60mg - pamidronate disodium 60mg - bone resorption inhibitors

Kanada - İngilizce - Health Canada

pharmascience inc - pamidronate disodium - powder for solution - 15mg - pamidronate disodium 15mg - bone resorption inhibitors

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - pamidronate disodium, quantity: 3 mg/ml - injection, concentrated - excipient ingredients: mannitol; sodium hydroxide; phosphoric acid; water for injections - treatment of conditions associated with increased osteoclast activity: ? predominantly lytic bone metastases from breast cancer and advanced multiple myeloma. ? acute management of tumour induced hypercalcaemia (hypercalcaemia of malignancy). ? treatment of symptomatic paget?s disease of bone.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - pamidronate disodium, quantity: 3 mg/ml - injection, concentrated - excipient ingredients: mannitol; sodium hydroxide; phosphoric acid; water for injections - treatment of conditions associated with increased osteoclast activity: ? predominantly lytic bone metastases from breast cancer and advanced multiple myeloma. ? acute management of tumour induced hypercalcaemia (hypercalcaemia of malignancy). ? treatment of symptomatic paget?s disease of bone.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - pamidronate disodium, quantity: 3 mg - injection, concentrated - excipient ingredients: mannitol; water for injections; sodium hydroxide; phosphoric acid - this drug is indicated for osteogenic bone metastasis of malignant tumors and malignant hypercalcemia.